"SICHUAN BIOKIN PHARMACEUTICAL CO., LTD."Announcement on the Voluntary Disclosure of the Completion of Enrollment of the First Subject in the Phase III Clinical Trial of T-Bren (HER2 ADC) for Injection in Patients with HER2-Expressing Locally Advanced or Metastatic Biliary Tract Cancer Who Failed Platinum-Based Chemotherapy

Announcement on the Voluntary Disclosure of the Completion of Enrollment of the First Subject in the Phase III Clinical Trial of T-Bren (HER2 ADC) for Injection in Patients with HER2-Expressing Locally Advanced or Metastatic Biliary Tract Cancer Who Failed Platinum-Based Chemotherapy

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment